Literature DB >> 22418039

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer.

Debbie Saslow1, Diane Solomon, Herschel W Lawson, Maureen Killackey, Shalini L Kulasingam, Joanna M Cain, Francisco A R Garcia, Ann T Moriarty, Alan G Waxman, David C Wilbur, Nicolas Wentzensen, Levi S Downs, Mark Spitzer, Anna-Barbara Moscicki, Eduardo L Franco, Mark H Stoler, Mark Schiffman, Philip E Castle, Evan R Myers, David Chelmow, Abbe Herzig, Jane J Kim, Walter Kinney, W Lawson Herschel, Jeffrey Waldman.   

Abstract

An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical precancerous lesions and cancer is presented. The guidelines are based on a systematic evidence review, contributions from six working groups, and a recent symposium co-sponsored by the ACS, American Society for Colposcopy and Cervical Pathology (ASCCP), and American Society for Clinical Pathology (ASCP), which was attended by 25 organizations. The new screening recommendations address age-appropriate screening strategies, including the use of cytology and high-risk human papillomavirus (HPV) testing, follow-up (e.g., management of screen positives and screening interval for screen negatives) of women after screening, age at which to exit screening, future considerations regarding HPV testing alone as a primary screening approach, and screening strategies for women vaccinated against HPV16/18 infections.

Entities:  

Mesh:

Year:  2012        PMID: 22418039      PMCID: PMC3915715          DOI: 10.1097/LGT.0b013e31824ca9d5

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  150 in total

Review 1.  Chapter 2: The burden of HPV-related cancers.

Authors:  D Maxwell Parkin; Freddie Bray
Journal:  Vaccine       Date:  2006-08-31       Impact factor: 3.641

2.  The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period.

Authors:  Susanne Kjaer; Estrid Høgdall; Kirsten Frederiksen; Christian Munk; Adriaan van den Brule; Edith Svare; Chris Meijer; Attilla Lorincz; Thomas Iftner
Journal:  Cancer Res       Date:  2006-10-23       Impact factor: 12.701

3.  Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.

Authors:  Xavier Castellsagué; Mireia Díaz; Silvia de Sanjosé; Nubia Muñoz; Rolando Herrero; Silvia Franceschi; Rosanna W Peeling; Rhoda Ashley; Jennifer S Smith; Peter J F Snijders; Chris J L M Meijer; F Xavier Bosch
Journal:  J Natl Cancer Inst       Date:  2006-03-01       Impact factor: 13.506

Review 4.  Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia.

Authors:  William Patrick Soutter; Peter Sasieni; Theo Panoskaltsis
Journal:  Int J Cancer       Date:  2006-04-15       Impact factor: 7.396

Review 5.  Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.

Authors:  Marc Arbyn; Peter Sasieni; Chris J L M Meijer; Christine Clavel; George Koliopoulos; Joakim Dillner
Journal:  Vaccine       Date:  2006-08-31       Impact factor: 3.641

Review 6.  Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies.

Authors:  George Koliopoulos; Marc Arbyn; Pierre Martin-Hirsch; Maria Kyrgiou; Walter Prendiville; Evangelos Paraskevaidis
Journal:  Gynecol Oncol       Date:  2006-11-03       Impact factor: 5.482

Review 7.  American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors.

Authors:  Debbie Saslow; Philip E Castle; J Thomas Cox; Diane D Davey; Mark H Einstein; Daron G Ferris; Sue J Goldie; Diane M Harper; Walter Kinney; Anna-Barbara Moscicki; Kenneth L Noller; Cosette M Wheeler; Terri Ades; Kimberly S Andrews; Mary K Doroshenk; Kelly Green Kahn; Christy Schmidt; Omar Shafey; Robert A Smith; Edward E Partridge; Francisco Garcia
Journal:  CA Cancer J Clin       Date:  2007 Jan-Feb       Impact factor: 508.702

Review 8.  Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination.

Authors:  Eduardo L Franco; Jack Cuzick; Allan Hildesheim; Silvia de Sanjosé
Journal:  Vaccine       Date:  2006-06-08       Impact factor: 3.641

9.  Overview of the European and North American studies on HPV testing in primary cervical cancer screening.

Authors:  Jack Cuzick; Christine Clavel; Karl-Ulrich Petry; Chris J L M Meijer; Heike Hoyer; Samuel Ratnam; Anne Szarewski; Philippe Birembaut; Shalini Kulasingam; Peter Sasieni; Thomas Iftner
Journal:  Int J Cancer       Date:  2006-09-01       Impact factor: 7.396

10.  Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies.

Authors:  Amy Berrington de González; Jane Green
Journal:  Int J Cancer       Date:  2007-02-15       Impact factor: 7.396

View more
  100 in total

1.  A Suggested Approach to Simplify and Improve Cervical Screening in the United States.

Authors:  Mark Schiffman; Nicolas Wentzensen
Journal:  J Low Genit Tract Dis       Date:  2016-01       Impact factor: 1.925

2.  Determinants of Abnormal Cervical Cancer Screening Follow-Up And Invasive Cervical Cancer Among Uninsured and Underinsured Women in New Jersey.

Authors:  Jennifer Tsui; Adana A Llanos; Michelle Doose; David Rotter; Antoinette Stroup
Journal:  J Health Care Poor Underserved       Date:  2019

Review 3.  Advances in technologies for cervical cancer detection in low-resource settings.

Authors:  Kathryn A Kundrod; Chelsey A Smith; Brady Hunt; Richard A Schwarz; Kathleen Schmeler; Rebecca Richards-Kortum
Journal:  Expert Rev Mol Diagn       Date:  2019-08-01       Impact factor: 5.225

4.  Ecological Association of Human Papillomavirus Vaccination with Cervical Dysplasia Prevalence in the United States, 2007-2014.

Authors:  Elaine W Flagg; Elizabeth A Torrone; Hillard Weinstock
Journal:  Am J Public Health       Date:  2016-10-13       Impact factor: 9.308

5.  Five-year risk of CIN 3+ to guide the management of women aged 21 to 24 years.

Authors:  Hormuzd A Katki; Mark Schiffman; Philip E Castle; Barbara Fetterman; Nancy E Poitras; Thomas Lorey; Li C Cheung; Tina Raine-Bennett; Julia C Gage; Walter K Kinney
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

6.  Five-year risks of CIN 2+ and CIN 3+ among women with HPV-positive and HPV-negative LSIL Pap results.

Authors:  Hormuzd A Katki; Mark Schiffman; Philip E Castle; Barbara Fetterman; Nancy E Poitras; Thomas Lorey; Li C Cheung; Tina Raine-Bennett; Julia C Gage; Walter K Kinney
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

7.  Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive.

Authors:  Hormuzd A Katki; Mark Schiffman; Philip E Castle; Barbara Fetterman; Nancy E Poitras; Thomas Lorey; Li C Cheung; Tina Raine-Bennett; Julia C Gage; Walter K Kinney
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

8.  Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.

Authors:  Hormuzd A Katki; Julia C Gage; Mark Schiffman; Philip E Castle; Barbara Fetterman; Nancy E Poitras; Thomas Lorey; Li C Cheung; Tina Raine-Bennett; Walter K Kinney
Journal:  J Low Genit Tract Dis       Date:  2013-04       Impact factor: 1.925

9.  Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies.

Authors:  Mona Saraiya; Vicki B Benard; April A Greek; Martin Steinau; Sonya Patel; L Stewart Massad; George F Sawaya; Elizabeth R Unger
Journal:  Am J Obstet Gynecol       Date:  2014-05-06       Impact factor: 8.661

10.  A cervical abnormality risk prediction model: can we use clinical information to predict which patients with ASCUS/LSIL Pap tests will develop CIN 2/3 or AIS?

Authors:  Brittany M Charlton; Jenny L Carwile; Karin B Michels; Sarah Feldman
Journal:  J Low Genit Tract Dis       Date:  2013-07       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.